首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1705889

全球医药合约销售外包（CSO）市场按服务类型、治疗领域、最终用户和地区划分

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, By Therapeutic Area, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球医药合约销售外包 (CSO) 市场规模估计为 107.289 亿美元，预计到 2032 年将达到 193.624 亿美元，2025 年至 2032 年的复合年增长率为 8.8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	107.289亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	8.80%	2032年价值预测	193.624亿美元

数字。 2025年全球市场占有率（%）

近年来，全球医药合约销售外包（CSO）市场呈现出良好的成长动能。为了专注于药物研发，製药商越来越多地将其销售和行销业务委託给专业的 CSO 供应商。 CSO公司协助製药商优化销售业务、管理经销商存取并确保促销符合监管指南。 CSO 利用数据主导的洞察力和技术解决方案来提高销售负责人的效率并扩大医生的覆盖范围。外包模式使製药公司能够获得专业知识并简化业务，而无需承担高昂的固定成本。这种具有成本效益的方法正在获得寻求简化商业化活动的生物製药公司的支持。

市场动态：

全球医药合约销售外包（CSO）市场受到生物製药公司优化营运成本和提高生产力的需求等因素的驱动。此外，药品促销法规日益复杂，尤其是在美国，这促使製药公司将其销售业务委託给熟悉合规框架的专业 CSO 提供者。此外，客户关係管理和数据分析技术的进步正在推动对外包销售业务的需求。然而，药品价格环境波动和某些地区不利的医疗改革给市场参与者带来了挑战。此外，CSO 产业格局的整合将影响客户关係。新的商业机会在于扩展到非传统治疗领域并提供附加价值服务。

企业对简化销售流程和提高效率的需求不断增加，这可能会进一步推动对销售计划和绩效分析软体的需求。例如，数位科技公司Accenture和软体公司销售团队 Inc. 于 2024 年 11 月 7 日宣布合作，为生命科学公司建立支援人工智慧 (AI) 的云端服务。透过此次合作，Accenture将把其在生物医学研究产业和人工智慧技术方面的独特专业知识添加到销售团队的生命科学云中，帮助实现新的软体使命，从而提高医疗技术、生物技术和製药公司的效率。

本研究的主要特点

本报告对全球医药合约销售外包 (CSO) 市场进行了详细分析，并以 2024 年为基准年，展示了预测期 (2025-2032) 的市场规模和复合年增长率。
它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
该报告涵盖了全球製药合约销售外包（CSO）市场的主要企业概况，基于公司亮点、产品系列、关键亮点、财务表现和策略等参数。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球製药业务销售外包（CSO）市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球医药分销外包 (CSO) 市场所使用的各种策略矩阵来简化决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 10,728.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 19,362.4 Mn

The global pharmaceutical contract sales outsourcing (CSO) market has shown promising growth in recent years. Pharmaceutical manufacturers are increasingly outsourcing their sales and marketing operations to specialized CSO providers in order to focus on drug research and development. CSO firms assist drug makers in optimizing sales operations, managing representative visits, and ensuring promotional compliance with regulatory guidelines. They leverage data-driven insights and technological solutions to enhance sales representative effectiveness and expand physician reach. The outsourcing model enables pharmaceutical companies to access specialized expertise and achieve operational efficiencies without incurring high fixed costs. This cost-effective approach has thus gained traction among biopharma firms looking to streamline commercialization activities.

Market Dynamics:

The global pharmaceutical contract sales outsourcing (CSO) market is driven by factors such as the need of biopharma players to optimize sales costs and boost productivity. Growing complexity of drug promotion regulations particularly in the U.S. also prompts pharmaceutical companies to outsource sales operations to specialized CSO providers well-versed with compliance frameworks. Additionally, technological advancements in customer relationship management and data analytics are translating into increased demand for outsourced sales capabilities. However, volatility in drug pricing environments and unfavorable healthcare reforms in certain regions pose challenges to market players. Furthermore, consolidation in the CSO industry landscape impacts client relationships. Emerging opportunities lie in expansion into non-traditional therapeutic areas and offering value-added services around market access.

Increasing requirement for companies to streamline the sales process and achieve higher efficiency will further aid in the demand for sales planning/performance analytics software. For instance, on November 7, 2024, Accenture, a digital technology company, and Salesforce, Inc., a software company, announced the collaboration to build an Artificial intelligence (AI) powered cloud service for life sciences companies. Under the collaborations, Accenture added its own expertise both in the biomedical research industry and in artificial intelligence technologies to the Salesforce Life Sciences Cloud to help fulfill the new software's mission of making medtech, biotech, and pharma companies more efficient.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical contract sales outsourcing (CSO) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical contract sales outsourcing (CSO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical contract sales outsourcing (CSO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical contract sales outsourcing (CSO) market

Detailed Segmentation:

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type
- Personal Promotion
- Non-personal Promotion
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area
- Cardiovascular Disorders
- Oncology
- Metabolic Disorders
- Neurology
- Orthopedic Diseases
- Infectious Diseases
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User
- Biopharmaceutical Companies
- Medical Device Companies
- Generic Companies
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company (TMAC)
- Ashfield Healthcare Communications Group
- GTS Solutions

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Service Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Digital technology adoption
- Access to care disparities
- Population health initiatives
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Non-personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Orthopedic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Generic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- IQVIA Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Syneos Health Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Parexel International Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- PPD
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- ICON plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Publicis Touchpoint Solutions, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Strategies
- PRA Health Sciences, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- The Medical Affairs Company (TMAC)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Ashfield Healthcare Communications Group
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GTS Solutions
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球医药合约销售外包（CSO）市场按服务类型、治疗领域、最终用户和地区划分